The study, conducted by notable researchers Santos, Robinson, and Trueman, sought to extrapolate clinical data to estimate the long-term durability of Valoctocogene Roxaparvovec treatment. Subject of Research: Long-Term Durability of Valoctocogene Roxaparvovec Treatment in Severe Hemophilia A. Article Title: Estimated Long-Term Durability of Valoctocogene Roxaparvovec Treatment in Male patients with Severe Hemophilia A: An Extrapolation of Clinical Data. & Trueman, D. Estimated Long-Term Durability of Valoctocogene Roxaparvovec Treatment in Male patients with Severe Hemophilia A: An Extrapolation of Clinical Data. https://doi.org/10.1007/s12325-025-03368-4Image Credits: AI GeneratedDOI: 10.1007/s12325-025-03368-4Keywords: Hemophilia A, gene therapy, Valoctocogene Roxaparvovec, factor VIII, long-term durability, clinical trial, treatment efficacy.